DDIT4 and Parkinson disease: In addition, the REDD1 level was increased in the substantia nigra neurons of patients with PD, and treatment with the dopaminergic neurotoxin 6-OHDA increased REDD1 expression and cell death, along with inhibition mTORC1 activity in neuronal PC12 cells145,146.